Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Fund Type: Open-End Fund
  • Objective: Health Care Sector
  • Asset Class: Equity
  • Geographic Focus: Global

Adamant Global Medtech und Services

+ Add to Watchlist

ADAGMED:SW

1,682.01 CHF 30.62 1.85%

As of 11:50:00 ET on 03/02/2015.

Snapshot for Adamant Global Medtech und Services (ADAGMED)

Year To Date: +4.74% 3-Month: +7.59% 3-Year: +18.79% 52-Week Range: 1,142.06 - 1,694.60
1-Month: +11.67% 1-Year: +38.91% 5-Year: +9.00% Beta vs SMI: 1.07

Mutual Fund Chart for ADAGMED

No chart data available.
  • ADAGMED:SW 1,682.01
  • 1M
  • 1Y
Interactive ADAGMED Chart

Previous Close

No chart data available.
Interactive Chart
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for ADAGMED

Adamant Global Medtech und Services is an open-ended investment company incorporated in Switzerland. The Fund's aim is to generate long-term capital growth through active management by investing in companies within the medicinal sector. The Fund's portfolio will be concentarted to around 30 to 50 stocks which fully meet Adamant's strict selection criteria.

Inception Date: 03-03-2008 Telephone: +41 800 850 050
Managers: JOHN MANIERI
Web Site: www.zkb.ch/fonds

Fundamentals for ADAGMED

NAV (on 2015-03-02) 1,682.01
Assets (M) (on 2015-03-02) 101.01
Fund Leveraged N
Minimum Investment -
Minimum Subsequent Investment -

Dividends for ADAGMED

Dividend Type Omitted
Dividend Frequency Irreg
Last Dividend Net -
Dividend Yield (ttm) -

Fees & Expenses for ADAGMED

Front Load 2.50
Back Load 1.00
Current Mgmt Fee 1.81
Redemption Fee 1.00
12b1 Fee -
Expense Ratio 1.84

Top Fund Holdings for ADAGMED

Filing Date: 10/31/2014
Name Position Value % of Total
UnitedHealth Group Inc 115,000 10,515,873 11.365%
Medtronic PLC 150,000 9,840,089 10.635%
Abbott Laboratories 200,000 8,390,639 9.068%
McKesson Corp 26,000 5,090,071 5.501%
Stryker Corp 57,500 4,843,987 5.235%
Cigna Corp 50,000 4,791,557 5.178%
Aetna Inc 60,000 4,764,705 5.149%
Baxter International Inc 65,000 4,387,906 4.742%
Express Scripts Holding Co 57,000 4,214,318 4.555%
St Jude Medical Inc 65,000 4,014,427 4.339%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil